F&FFinancial Insights

Financial Metrics

BG Bunge Global SA
Range: 2016-01-01 to 2026-04-29
Chart Range:
% Change:

Financial Statements

Grouped by statement

Income Statement

Metrics: 6

Revenue

Q: 9 | A: 5

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2023-03-31 15328000000.0 USD 10-Q 2024-04-24
Quarterly 2023-06-30 15049000000.0 -1.8% USD 10-Q 2024-08-01
Quarterly 2023-09-30 14227000000.0 -5.5% USD 10-Q 2024-10-30
Quarterly 2024-03-31 13417000000.0 -5.7% USD 10-Q 2025-05-07
Quarterly 2024-06-30 13241000000.0 -1.3% USD 10-Q 2025-08-05
Quarterly 2024-09-30 12908000000.0 -2.5% USD 10-Q 2025-11-05
Quarterly 2025-03-31 11643000000.0 -9.8% USD 10-Q 2025-05-07
Quarterly 2025-06-30 12769000000.0 +9.7% USD 10-Q 2025-08-05
Quarterly 2025-09-30 22155000000.0 +73.5% USD 10-Q 2025-11-05
Annual 2021-12-31 59152000000.0 USD 10-K 2024-02-22
Annual 2022-12-31 67232000000.0 +13.7% USD 10-K 2025-02-20
Annual 2023-12-31 59540000000.0 -11.4% USD 10-K 2026-02-19
Annual 2024-12-31 13542000000.0 -77.3% USD 10-K 2026-02-19
Annual 2025-12-31 23762000000.0 +75.5% USD 10-K 2026-02-19

Gross Profit

Q: 9 | A: 5

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2023-03-31 1181000000.0 USD 10-Q 2024-04-24
Quarterly 2023-06-30 1365000000.0 +15.6% USD 10-Q 2024-08-01
Quarterly 2023-09-30 1045000000.0 -23.4% USD 10-Q 2024-10-30
Quarterly 2024-03-31 876000000.0 -16.2% USD 10-Q 2025-05-07
Quarterly 2024-06-30 664000000.0 -24.2% USD 10-Q 2025-08-05
Quarterly 2024-09-30 772000000.0 +16.3% USD 10-Q 2025-11-05
Quarterly 2025-03-31 597000000.0 -22.7% USD 10-Q 2025-05-07
Quarterly 2025-06-30 738000000.0 +23.6% USD 10-Q 2025-08-05
Quarterly 2025-09-30 1063000000.0 +44.0% USD 10-Q 2025-11-05
Annual 2021-12-31 3363000000.0 USD 10-K 2024-02-22
Annual 2022-12-31 3682000000.0 +9.5% USD 10-K 2025-02-20
Annual 2023-12-31 4845000000.0 +31.6% USD 10-K 2026-02-19
Annual 2024-12-31 1081000000.0 -77.7% USD 10-K 2026-02-19
Annual 2025-12-31 1011000000.0 -6.5% USD 10-K 2026-02-19

Operating Income

Q: 0 | A: 0

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed

Net Income

Q: 9 | A: 5

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2023-03-31 659000000.0 USD 10-Q 2024-04-24
Quarterly 2023-06-30 629000000.0 -4.6% USD 10-Q 2024-08-01
Quarterly 2023-09-30 389000000.0 -38.2% USD 10-Q 2024-10-30
Quarterly 2024-03-31 252000000.0 -35.2% USD 10-Q 2025-05-07
Quarterly 2024-06-30 73000000.0 -71.0% USD 10-Q 2025-08-05
Quarterly 2024-09-30 233000000.0 +219.2% USD 10-Q 2025-11-05
Quarterly 2025-03-31 204000000.0 -12.4% USD 10-Q 2025-05-07
Quarterly 2025-06-30 370000000.0 +81.4% USD 10-Q 2025-08-05
Quarterly 2025-09-30 181000000.0 -51.1% USD 10-Q 2025-11-05
Annual 2021-12-31 2167000000.0 USD 10-K 2024-02-22
Annual 2022-12-31 1678000000.0 -22.6% USD 10-K 2025-02-20
Annual 2023-12-31 2337000000.0 +39.3% USD 10-K 2026-02-19
Annual 2024-12-31 630000000.0 -73.0% USD 10-K 2026-02-19
Annual 2025-12-31 88000000.0 -86.0% USD 10-K 2026-02-19

EPS Basic

Q: 9 | A: 5

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2023-03-31 4.21 USD/shares 10-Q 2024-04-24
Quarterly 2023-06-30 4.13 -1.9% USD/shares 10-Q 2024-08-01
Quarterly 2023-09-30 2.5 -39.5% USD/shares 10-Q 2024-10-30
Quarterly 2024-03-31 1.7 -32.0% USD/shares 10-Q 2025-05-07
Quarterly 2024-06-30 0.49 -71.2% USD/shares 10-Q 2025-08-05
Quarterly 2024-09-30 1.57 +220.4% USD/shares 10-Q 2025-11-05
Quarterly 2025-03-31 1.5 -4.5% USD/shares 10-Q 2025-05-07
Quarterly 2025-06-30 2.63 +75.3% USD/shares 10-Q 2025-08-05
Quarterly 2025-09-30 0.84 -68.1% USD/shares 10-Q 2025-11-05
Annual 2021-12-31 14.5 USD/shares 10-K 2024-02-22
Annual 2022-12-31 10.83 -25.3% USD/shares 10-K 2025-02-20
Annual 2023-12-31 15.07 +39.2% USD/shares 10-K 2026-02-19
Annual 2024-12-31 4.41 -70.7% USD/shares 10-K 2026-02-19
Annual 2025-12-31 0.49 -88.9% USD/shares 10-K 2026-02-19

EPS Diluted

Q: 9 | A: 5

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2023-03-31 4.15 USD/shares 10-Q 2024-04-24
Quarterly 2023-06-30 4.09 -1.4% USD/shares 10-Q 2024-08-01
Quarterly 2023-09-30 2.47 -39.6% USD/shares 10-Q 2024-10-30
Quarterly 2024-03-31 1.68 -32.0% USD/shares 10-Q 2025-05-07
Quarterly 2024-06-30 0.48 -71.4% USD/shares 10-Q 2025-08-05
Quarterly 2024-09-30 1.56 +225.0% USD/shares 10-Q 2025-11-05
Quarterly 2025-03-31 1.48 -5.1% USD/shares 10-Q 2025-05-07
Quarterly 2025-06-30 2.61 +76.4% USD/shares 10-Q 2025-08-05
Quarterly 2025-09-30 0.84 -67.8% USD/shares 10-Q 2025-11-05
Annual 2021-12-31 13.64 USD/shares 10-K 2024-02-22
Annual 2022-12-31 10.51 -22.9% USD/shares 10-K 2025-02-20
Annual 2023-12-31 14.87 +41.5% USD/shares 10-K 2026-02-19
Annual 2024-12-31 4.36 -70.7% USD/shares 10-K 2026-02-19
Annual 2025-12-31 0.49 -88.8% USD/shares 10-K 2026-02-19

8-K Material Event Details

48 filings · 112 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

44 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value

All Transactions

Date Insider Title Type Security Shares Price Total Value Post-Tx Shares
2026-03-15 Podwika Joseph Chief Legal Officer Equity grant / award
A
Common Stock 5,571 $0.00 $0 92,002
2026-03-15 Podwika Joseph Chief Legal Officer Other disposed transaction
F
Common Stock 5,074 $125.63 $637,447 86,431
2026-03-15 Podwika Joseph Chief Legal Officer Equity grant / award
A
Common Stock 5,858 $0.00 $0 91,505
2026-03-03 Dimopoulos Christos EVP and CSO Equity grant / award
A
Common Stock 171 $116.83 $19,978 104,915
2026-02-11 Garros Julio Chief Operating Officer Exercise / conversion
M · derivative
Stock Options (Right to buy) 6,500 $0.00 $0 0
2026-02-11 Garros Julio Chief Operating Officer Open-market sell
S
Common Stock 2,831 $119.00 $336,889 127,796
2026-02-11 Garros Julio Chief Operating Officer Exercise / conversion
M
Common Stock 6,500 $50.07 $325,455 130,627
2025-12-01 Neppl John W Chief Financial Officer Equity grant / award
A
Common Stock 304 $96.47 $29,327 137,754
2025-11-21 Dimopoulos Christos Executive VP, Global Markets Exercise / conversion
M · derivative
Stock Options (Right to buy) 5,300 $0.00 $0 0
2025-11-21 Dimopoulos Christos Executive VP, Global Markets Open-market sell
S
Common Stock 20,000 $94.37 $1,887,418 104,537
2025-11-21 Dimopoulos Christos Executive VP, Global Markets Open-market sell
S
Common Stock 5,300 $94.38 $500,226 124,537
2025-11-21 Dimopoulos Christos Executive VP, Global Markets Exercise / conversion
M
Common Stock 5,300 $50.07 $265,371 129,837
2025-09-02 Jensen Anne Dir Equity grant / award
A
Common Stock 18 $82.44 $1,484 2,182
2025-08-18 Mahoney Christopher Dir Open-market buy
P
Common Stock 5,000 $81.73 $408,650 7,164
2025-07-16 Mattiske David Co-Chief Operating Officer Equity grant / award
A
Common Stock 10,456 $0.00 $0 151,486
2025-07-16 Mattiske David Co-Chief Operating Officer Equity grant / award
A
Common Stock 42,905 $0.00 $0 141,030
2025-07-16 Mattiske David Co-Chief Operating Officer Equity grant / award
A
Common Stock 41,656 $0.00 $0 98,125
2025-07-02 Jensen Anne Dir Equity grant / award
A
Common Stock 2,164 $0.00 $0 2,164
2025-06-02 Jojo Linda P Dir Equity grant / award
A
Common Stock 22 $77.87 $1,713 2,532
2025-05-15 Zenuk Mark N Dir Equity grant / award
A
Common Stock 4,707 $0.00 $0 21,757
2025-05-15 Zenuk Mark N Dir Other disposed transaction
F
Common Stock 753 $79.65 $59,976 17,050
2025-03-15 Dimopoulos Christos Co-President, Agribusiness Equity grant / award
A
Common Stock 10,906 $0.00 $0 124,045
2025-03-15 Dimopoulos Christos Co-President, Agribusiness Other disposed transaction
F
Common Stock 1,829 $73.35 $134,157 113,139
2025-03-15 Dimopoulos Christos Co-President, Agribusiness Equity grant / award
A
Common Stock 26,225 $0.00 $0 114,968
2025-03-15 Podwika Joseph Chief Legal Officer Other disposed transaction
F
Common Stock 579 $73.35 $42,470 84,921
2025-03-04 Simril Kenneth Dir Equity grant / award
A
Common Stock 18 $71.86 $1,293 6,714
2024-12-02 McGurk Monica Houle Dir Equity grant / award
A
Common Stock 15 $88.62 $1,329 3,970
2024-09-02 Garros Julio Co-President, Agribusiness Equity grant / award
A
Common Stock 179 $100.95 $18,070 90,549
2024-06-03 Neppl John W Chief Financial Officer Equity grant / award
A
Common Stock 206 $107.37 $22,118 107,889
2024-05-22 Dimopoulos Christos Co-President, Agribusiness Open-market sell
S
Common Stock 20,000 $103.26 $2,065,200 87,999
2024-05-15 Lustosa de Andrade Eliane Aleixo Dir Equity grant / award
A
Common Stock 1,947 $0.00 $0 4,443
2024-05-11 Browner Carol M. Dir Other disposed transaction
F
Common Stock 302 $105.06 $31,728 25,510
2024-03-15 HECKMAN GREGORY A Chief Executive Officer Equity grant / award
A
Common Stock 46,318 $0.00 $0 363,538
2024-03-15 HECKMAN GREGORY A Chief Executive Officer Other disposed transaction
F
Common Stock 23,737 $95.00 $2,254,896 317,220
2024-03-15 HECKMAN GREGORY A Chief Executive Officer Other disposed transaction
F
Common Stock 71,684 $95.00 $6,809,622 340,957
2024-03-15 HECKMAN GREGORY A Chief Executive Officer Equity grant / award
A
Common Stock 162,364 $0.00 $0 412,641
2024-03-01 Bair Sheila Colleen Dir Equity grant / award
A
Common Stock 16 $93.68 $1,499 11,383
2024-02-22 Garros Julio Co-President, Agribusiness Exercise / conversion
M · derivative
Stock Options (Right to buy) 3,300 $0.00 $0 0
2024-02-22 Garros Julio Co-President, Agribusiness Other disposed transaction
F
Common Stock 2,814 $93.20 $262,279 72,888
2024-02-22 Garros Julio Co-President, Agribusiness Exercise / conversion
M
Common Stock 3,300 $79.47 $262,251 75,702
2024-02-16 Dimopoulos Christos Co-President, Agribusiness Exercise / conversion
M · derivative
Stock Options (Right to buy) 2,700 $0.00 $0 0
2024-02-16 Dimopoulos Christos Co-President, Agribusiness Other disposed transaction
F
Common Stock 2,377 $91.00 $216,307 73,862
2024-02-16 Dimopoulos Christos Co-President, Agribusiness Exercise / conversion
M
Common Stock 2,700 $79.47 $214,569 76,239
2023-12-01 Hees Bernardo Dir Equity grant / award
A
Common Stock 13 $109.69 $1,426 10,867

Regulatory Activity

Last 12 months to 2025-04-29
Insider Filings (Forms 3/4/5) — 12 months
13
Material Event Filings (8-K) — 12 months
23

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count
For informational purposes only — not guaranteed to be accurate or complete.